Presentation title
“Translational Justice and Health Disparities Research in Genomics”

Traditional models of clinical translation of genetic therapies have focused on metrics of safety, efficacy, and cost. However, wide disparities in the use and benefits of genetic medicine suggest that these metrics have not been successful in guiding equitable translation. We propose a fourth metric and present examples of how it can be operationalized. 

Speaker
Megan Allyse, PhD
Associate Professor of Biomedical Ethics
Biomedical Ethics Research Program in Biomedical Ethics Research
Quantitative Health Sciences and Obstetrics and Gynecology
Mayo Clinic, Florida

LEARNING OBJECTIVES:

1. Explain practical applications of genomics and pharmacogenomics for individualizing patient care.

2. Define strategies to overcome obstacles to implementing genomic sequencing for patient care.

3. Describe new and emerging technologies that promote individualized care for patients.

4. Discuss ethical, legal, and social issues arising from the translation of individualized medicine into the clinical practice and the promotion of molecular, cellular, and genomic medicine research.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.